Prognostic role of TEAD4 in TNBC: in-silico inhibition of the TEAD4-YAP interaction by flufenamic acid analogs-Reference-Cited by-同舟云学术

Prognostic role of TEAD4 in TNBC: in-silico inhibition of the TEAD4-YAP interaction by flufenamic acid analogs

Published:2024-07-17 Issue:2 Volume:12 Page:
ISSN:2193-9616
Container-title:In Silico Pharmacology
language:en
Short-container-title:In Silico Pharmacol.

Author:

Gupta Shradheya R. R.,Singh Shivani,Rustagi Vanshika,Pahuja Monika,Mangangcha Irengbam Rocky,Rinchui Moses,Jha Saurabh K.,Singh Archana,Singh Indrakant K.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40203-024-00239-8.pdf

Reference40 articles.

1. Abdul-Hammed M, Adedotun IO, Olajide M, Irabor CO, Afolabi TI, Gbadebo IO, Rhyman L, Ramasami P (2022) Virtual screening, ADMET profiling, PASS prediction, and bioactivity studies of potential inhibitory roles of alkaloids, phytosterols, and flavonoids against COVID-19 main protease (M(pro)). Nat Prod Res 36(12):3110–3116. https://doi.org/10.1080/14786419.2021.1935933

2. Ainsley J, Chaturvedi SS, Karabencheva-Christova TG, Tanasova M, Christov CZ (2018) Integrating molecular probes and molecular dynamics to reveal binding modes of GLUT5 activatory and inhibitory ligands [10.1039/C8CC04843F]. Chem Commun 54(71):9917–9920. https://doi.org/10.1039/C8CC04843F

3. Bharadwaj S, Dubey A, Kamboj NK, Sahoo AK, Kang SG, Yadava U (2021a) Drug repurposing for ligand-induced rearrangement of Sirt2 active site-based inhibitors via molecular modeling and quantum mechanics calculations. Sci Rep 11(1):10169. https://doi.org/10.1038/s41598-021-89627-0

4. Bharadwaj S, Dubey A, Yadava U, Mishra SK, Kang SG, Dwivedi VD (2021b) Exploration of natural compounds with anti-SARS-CoV-2 activity via inhibition of SARS-CoV-2 Mpro. Brief Bioinform 22(2):1361–1377. https://doi.org/10.1093/bib/bbaa382

5. Bissanum R, Chaichulee S, Kamolphiwong R, Navakanitworakul R, Kanokwiroon K (2021) Molecular classification models for Triple negative breast Cancer Subtype using machine learning. J Pers Med 11(9). https://doi.org/10.3390/jpm11090881